MedTrace Logo

High-intensity Training in an Enriched Environment in Late Phase After Stroke

NCT02889939 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2018-11-02

No results posted yet for this study

Summary

We designed an explorative clinical study to assess the effectiveness of an enriched intense and task-oriented therapy program in enhancing motor recovery in patients with moderate to moderately severe hemiplegia after stroke. This enriched comprehensive task-specific therapy (ETT) program combines intensive and task-specific therapy with the sensory-motor, social, and cognitive stimulation inherent to environmental enrichment. We also investigated whether ETT improves gait, balance, upper and lower limb function, and confidence in task performance, health-related quality of life (HRQoL) and reduces fatigue and depression.

Conditions

Interventions

OTHER

UC + ETT

UC: A 3-week UC period, where the participants were not offered any new rehabilitation activities but were allowed to continue their regular treatment for a maximum of 3 hours per week. ETT: The rehabilitation facilities were located in a climate that allowed and encouraged both indoor and outdoor activities. The ETT was individually tailored. Participants exercised in the same room/place as the other participants in groups of 4-9. Physical exercise was scheduled 3.5-6 hours per day, 5½ days per week for 3 weeks. The training was characterized by repetitive mass practice of gradually increasing difficulty and noncompensatory strategies, such as enforcing use of the affected side. Beyond scheduled activities, participants were encouraged to physically engage themselves in a challenging outdoor environment.

Sponsors & Collaborators

  • Wallström och Sjöbloms stiftelse

    collaborator UNKNOWN

  • Peter Erikssons minnesfond

    collaborator UNKNOWN

  • Back to Life

    collaborator UNKNOWN

  • Göteborg University

    lead OTHER

Principal Investigators

  • Lina Bunketorp Käll, PT, PhD · Göteborg University

  • Georg Kuhn, Professor · Göteborg University

  • Jean-Luc Af Geijerstam, MD, PhD · Karolinska Institutet

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2015-07-31
Completion
2017-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02889939 on ClinicalTrials.gov